TWD
HAE icon

True Wealth Design’s Haemonetics HAE Stock Holding History

True Wealth Design’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.1K Sell
282
-45
-14% -$2.89K 0.01% 787
2026
Q1 		$18.4K Sell
327
-13
-4% -$847 0.01% 749
2025
Q4 		$27.3K Buy
340
+335
+6,700% +$22.5K 0.01% 506
2025
Q3 		$244 Sell
5
-7
-58% -$433 ﹤0.01% 2255
2025
Q2 		$896 Buy
12
+1
+9% +$66 ﹤0.01% 1514
2025
Q1 		$700 Sell
11
-46
-81% -$3.13K ﹤0.01% 1415
2024
Q4 		$4.45K Buy
+57
New +$4.58K ﹤0.01% 557

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

True Wealth Design's HAE Position: Q2 2026 in Review

True Wealth Design reduced its Haemonetics (HAE) stake by 14% in Q2 2026, selling an estimated $2.89K and leaving 282 shares worth $21.1K. The position accounts for 0.01% of the portfolio, ranked #787.

True Wealth Design first reported a position in HAE in Q4 2024 and has held it in 7 quarters since. The position peaked at $27.3K in Q4 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • True Wealth Design held 282 shares of Haemonetics worth $21.1K as of Q2 2026.
  • True Wealth Design sold 45 Haemonetics shares in Q2 2026, an estimated $2.89K.
  • Haemonetics made up 0.01% of True Wealth Design's portfolio in Q2 2026, its #787 holding.
  • True Wealth Design first reported a position in Haemonetics in Q4 2024 and has held it in 7 quarters since.
  • True Wealth Design's Haemonetics position peaked at $27.3K in Q4 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.